Free Trial

This company has been marked as potentially delisted and may not be actively trading.

LakeShore Biopharma (LSB) Institutional Ownership

LakeShore Biopharma logo

Institutional Ownership Changes (13F Filings) for LakeShore Biopharma (NASDAQ:LSB)

Current
Institutional Ownership
Percentage
52.64%
Number of
Institutional Buyers
(last 12 months)
0
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$87.34K
Get LSB Insider Trade Alerts

Want to know when executives and insiders are buying or selling LakeShore Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

LSB Institutional Buying and Selling by Quarter

LakeShore Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2025Orbimed Advisors LLC54,799$56K0.0%-61.0%0.264%
2/17/2025Orbimed Advisors LLC140,428$486K0.0%N/A1.508%
2/14/2025Hhlr Advisors LTD.75,179$259K0.0%-90.0%0.808%
2/13/2025Barclays PLC24,757$86K0.0%-90.0%0.266%
11/19/2024Barclays PLC247,575$169K0.0%N/A2.660%
11/15/2024Barclays PLC247,575$169K0.0%N/A2.660%
11/14/2024Hhlr Advisors LTD.751,790$513K0.0%N/A8.075%
11/13/2024FMR LLC1,165,071$803K0.0%N/A12.514%


LSB Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LSB shares?

During the previous two years, the following institutional investors and hedge funds held shares of LakeShore Biopharma shares: FMR LLC ($803K), Hhlr Advisors LTD. ($259K), and Barclays PLC ($86K), Orbimed Advisors LLC ($56K).Learn more on LakeShore Biopharma's institutional investors.

What percentage of LakeShore Biopharma's stock is owned by institutional investors?

52.64% of LakeShore Biopharma's stock is owned by institutional investors. Learn more on LSB's institutional investor holdings.

Which institutional investors have been buying LakeShore Biopharma's stock?

The following institutional investors have purchased LakeShore Biopharma's stock in the last 24 months: FMR LLC ($1.17M), Hhlr Advisors LTD. ($751.79K), Barclays PLC ($495.15K), and Orbimed Advisors LLC ($140.43K).

Which of LakeShore Biopharma's major shareholders have been selling company stock?

The following institutional investors have sold LakeShore Biopharma stock in the last 24 months: Orbimed Advisors LLC ($85.63K).

How much institutional selling is happening at LakeShore Biopharma?

Institutional investors have sold a total of 85,629 shares in the last 24 months. This volume of shares sold represents approximately $87.34K in transactions.



This page (NASDAQ:LSB) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners